Longeveron Inc: Clinical Trial Achieved Its Primary Safety and Secondary Efficacy Endpoints
龍駿醫藥:臨床試驗已達到主要的安全性和次要的有效性終點
Longeveron Inc: Clinical Trial Achieved Its Primary Safety and Secondary Efficacy Endpoints
龍駿醫藥:臨床試驗已達到主要的安全性和次要的有效性終點
譯文內容由第三人軟體翻譯。